Legend Biotech Corp (NAS:LEGN)
$ 40 -0.92 (-2.25%) Market Cap: 7.37 Bil Enterprise Value: 6.59 Bil PE Ratio: 0 PB Ratio: 6.47 GF Score: 63/100

Legend Biotech Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 10, 2021 / 12:45PM GMT
Release Date Price: $37.39 (-0.82%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Before I get started, I just need to read a disclaimer statement. Please note that all-important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.

So pleased to have Ying Huang, the CEO of Legend with us.

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Ying, I thought maybe just to start us off, I mean, I know there's not a lot to say, but it's obviously the focus for a lot of people, which is progress towards your PDUFA date and your first approval. So maybe just to the extent you can update people on where we are in that process.

Ying Huang
Legend Biotech Corporation - CEO & CFO

Sure. Thank you, Matthew, and Morgan Stanley for inviting Legend. So I know it's on top of the mind for many investors, and it's something we're also working on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot